SKI Market

A+| A| A-|

Indian Indices

Sensex

77,186.87 1.44
( 0.00%)

Global Indices

Nasdaq

52,663.96 134.69
(0.26%)

Dow Jones

7,591.19 26.60
(0.35%)

Hang Seng

66,873.37 -1,878.14
(-2.73%)

Nikkei 225

10,555.24 39.32
(0.37%)

Forex

USD-INR

96.14 0.39
(0.40%)

EUR-INR

109.70 0.52
(0.48%)

GBP-INR

128.61 0.54
(0.42%)

JPY-INR

0.59 0.00
(0.41%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Caplin Point Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524742

INE475E01026

269.7614245

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CAPLIPOINT

50.82

20151.08

EPS(TTM)

Face Value()

Div & Yield %

52.17

0.15

Back

sanchay finvest ltd

Oriental Aromatics reports consolidated net loss of Rs 1.92 crore in the December 2025 quarter

Feb 13,2026

Net loss of Oriental Aromatics reported to Rs 1.92 crore in the quarter ended December 2025 as against net profit of Rs 7.14 crore during the previous quarter ended December 2024. Sales rose 13.03% to Rs 251.56 crore in the quarter ended December 2025 as against Rs 222.57 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	251.56	222.57	13
OPM %	5.26	10.13	-
PBDT	5.98	16.28	-63
PBT	-1.84	9.88	PL
NP	-1.92	7.14	PL

77,186.87 1.44 ( 0.00%)

52,663.96 134.69 (0.26%)

7,591.19 26.60 (0.35%)

66,873.37 -1,878.14 (-2.73%)

10,555.24 39.32 (0.37%)

96.14 0.39 (0.40%)

109.70 0.52 (0.48%)

128.61 0.54 (0.42%)

0.59 0.00 (0.41%)